Mechanistic explanations for the chemopreventive action of soyabean isoflavones: Reducing the possibilities

British Journal of Nutrition

Volumn 88, Issue 5, 2002, Pages 439-441

  Ford, Dianne ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; ISOFLAVONE; PROTEIN BCL 2; PROTEIN PS2; PROTEIN TYROSINE KINASE; SOYBEAN OIL;

APOPTOSIS; BREAST CANCER; CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CHEMOPROPHYLAXIS; COLON CANCER; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE MODEL; ESTROGEN ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; NOTE; PREVENTIVE MEDICINE; PROSTATE CANCER; SOYBEAN;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; COLONIC NEOPLASMS; DIET; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; ISOFLAVONES; MALE; PROSTATIC NEOPLASMS; PROTEIN BINDING; RECEPTORS, ESTROGEN; SOYBEANS; TUMOR CELLS, CULTURED;

GLYCINE MAX; MINK CELL FOCUS-FORMING VIRUS;

EID: 0036848595     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN2002711     Document Type: Note

References (28)

1. Adlercreutz H, van der Wildt J, Kinzel J, Attalla H, Wahala K, Makela T, Hase T & Fotsis T (1995) Lignan and isoflavonoid conjugates in human urine. Journal of Steroid Biochemistry and Molecular Biology 52, 97-103.
2. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M & Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry 262, 5592-5595.
3. Balabhadrapathruni S, Thomas TJ, Yurkow EJ, Amenta PS & Thomas T (2000) Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Oncology Reports 7, 3-12.
4. Bingham SA, Atkinson C, Liggins J, Bluck L & Coward A (1998) Phyto-oestrogens: where are we now? British Journal of Nutrition 79, 393-406.
5. Boersma BJ, Barnes S, Kirk M, Wang C-C, Smith M, Kim H, Xu J, Patel R & Darley-Usmar VM (2001) Soy isoflavonoids and cancer - metabolism at the target site. Mutation Research 480-481, 121-127.
6. Burow ME, Weldon CB, Chiang TC, Tang Y, Collins-Burow BM, Rolfe K, Li S, McLachlan JA & Beckman BS (2000) Differences in protein kinase C and estrogen receptor alpha, beta expression and signalling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. International Journal of Oncology 16, 1179-1187.
7. Cheng EH, Levine B, Boise LH, Thompson CB & Hardwick JM (1996) Bax-independent inhibition of apoptosis by Bcl-XL. Nature 379, 554-556.
8. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI & Guild BC (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374, 733-736.
9. Ciocca DR & Elledge R (2000) Molecular markers for predicting response to tamoxifen in breast cancer patients. Endocrine 13, 1-10.
10. Davis NJ, Kucuk O & Sarkar FH (1999) Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutrition and Cancer 35, 167-174.
11. Imoto M, Yamashita T, Sawa T, Kurasawa S, Naganawa H, Takeuchi T, Bao-quan Z & Umezawa K (1988) Inhibition of cellular phosphatidylinositol turnover by psi-tectorigenin. FEBS Letters 230, 43-46.
12. Jacobs E, Bulpitt PC, Coutts IG & Robertson JF (2000) New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor status. Anticancer Drugs 11, 63-68.
13. Kim H, Xu J, Su Y, Xia H, Li L, Peterson G, Murphy-Ullrich J & Barnes S (2001) Actions of the soy phytoestrogen genistein in models of human chronic disease: potential involvement of transforming growth factor beta. Biochemical Society Transactions 29, 216-222.
14. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S & Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of the estrogen receptors alpha and beta. Endocrinology 138, 863-870.
15. Kulling SE, Honig DM & Metzler M (2001) Oxidative metabolism of the soy isoflavones daidzein and genistein in humans in vitro and in vivo. Journal of Agriculture and Food Chemistry 49, 3024-3033.
16. Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier JM, Le Pecq JB & Larsen AK (1989) Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian topoisomerase II. Cancer Research 49, 5111-5117.
17. Nenci I, Marchetti E & Querzoli P (1988) Commentary on human mammary pre-neoplasia: the estrogen receptor hypothesis. Journal of Steroid Biochemistry and Molecular Biology 30, 105-106.
18. Onozawa M, Kawamori T, Baba M, Fukuda K, Toda T, Sato H, Ohtani M, Akaza H, Sugimura T & Wakabayashi K (1999) Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats. Japanese Journal of Cancer Research 90, 393-398.
19. Peterson TG, Coward L, Kirk M, Falany CN & Barnes S (1996) The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis 17, 1861-1869.
20. Po LS, Wang TT, Chen Z-Y & Leung LK (2002) Genistein-induced apoptosis in cell lines involves changes in Bak and Bcl-x without evidence of anti-oestrogenic effects. British Journal of Nutrition 88, 463-469.
21. Roberts-Kirchoff ES, Crowley JR, Hollenberg PF & Kim H (1999) Metabolism of genistein by rat and human cytochrome P450s. Chemical Research in Toxicology 12, 610-616.
22. Salti GL, Grewal S, Mehta RR, Das Gupta TK, Brodie AW Jr & Constantinou AI (2000) Genistein induced apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. European Journal of Cancer 36, 796-802.
23. Schleicher RL, Lamartiniere CA, Zheng M & Zhang M (1999) The inhibitory effect of genistein on the growth and metastasis of a transplantable rat accessory gland carcinoma. Cancer Letters 136, 195-201.
24. Setchell KDR, Borriello SP, Humle P, Kirk DN & Axelson M (1984) Non-steroidal estrogens of dietary origin: possible roles in hormone-dependent disease. American Journal of Clinical Nutrition 40, 569-578.
25. Shao Z-M, Alpaugh ML, Fontana JA & Barsky SH (1998) Genistein inhibits proliferation similarly in estrogen receptor-positive and negative cell lines characterised by P21WAF1/CIP1 induction, G2/M arrest and apoptosis. Journal of Cellular Biochemistry 69, 44-54.
26. Suzuki K, Koike H, Matsui H, Ono Y, Hasumi M, Nakazato H, Okugi H, Sekine Y, Oki K, Yamamoto T, Fukabori Y, Kurokawa K & Yamanaka H (2002) Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. International Journal of Cancer 99, 846-852.
27. Wei H, Wei L, Frenkel K, Bowen R & Barnes S (1993) Inhibition of tumour promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutrition and Cancer 20, 1-12.
28. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL & Clinton SK (1999) Soybean phytochemicals inhibit the growth of transplantable prostate carcinoma and tumour angiogenesis in mice. Journal of Nutrition 129, 1628-1635.